LabWare Supports the COVID-19 Effort at the Instituto Butantan in Brazil

Instituto Butantan supplies 90% of the antivenin and 65% of all vaccines to the Brazilian public health system. Out of the 170 million doses of vaccines dispensed annually by the Brazilian immunization program, Instituto Butantan produces 100 million units. In particular, they manufacture 100% of the influenza vaccine doses used by the Ministry of Health. Currently, the most significant flu vaccine manufacturer in the Southern Hemisphere, Instituto Butantan in already processing COVID-19 samples and will coordinate a network of 38 Laboratories in the São Paulo area.